$1.07
-0.02 (-1.83%)
REI News30 articles
WELL Health Rises After Acquiring Canadian Clinics at Attractive Multiple
WELL Health Technologies shares rose 3.1% after buying two Canadian clinics at a price lower than its own public valuation.
Keel Infrastructure Stock Plunge Brings Convertible Note Terms Into Focus
Keel Infrastructure shares dropped 14.68% to $4.59, erasing $477M in market cap, more than the $445.4M net from June convertible notes. The stock remains below the $7.41 conversion price.
T1 Energy Shares Slide as Expiring Warrants, Convertible Notes Weigh
T1 Energy shares dropped 6.8% to $8.56 as the market focuses on next week's warrant expiration and in-the-money convertible notes, with key price levels under watch.
Regencell Bioscience Shares Slide 63% Below May Offering Price
Regencell Bioscience (NASDAQ:RGC) dropped 6.6% to $7.50, remaining 63.1% below its May offering price, despite a brief intraday rebound. Biotech ETFs gained.
Regencell Bioscience Surges But Still 60% Below May Offering Price
Regencell Bioscience (RGC) shares surged 31.9% on Wednesday, yet still trade 60.4% below the May direct offering price. The stark rebound underscores the volatility and fundamental challenges facing the pre-revenue biotech.
AWS $1B AI Engineering Initiative Lifts Amazon Stock Despite Cash Flow Concerns
Amazon shares gained 1.4% after-hours as AWS launched a $1B AI engineering program, offering a clearer revenue path for its massive AI capex.
Nu Holdings stock gains on heavy volume, nearing buyback limit
Nu Holdings shares rose 1.16% on heavy volume, with dollar turnover hitting 64% of its $1 billion buyback authorization, outperforming the Brazil ETF.
Progress Software Q2 Beats Estimates, But License Revenue Surge Raises Recurring Revenue Concerns
Progress Software beat Q2 estimates with 7% revenue growth, but license sales outpaced recurring revenue, leading to an after-hours stock decline.
Joby Aviation Shares Slide 24% Below January Stock Offering Price
Joby Aviation shares slid 2.2% to $8.64, trading well below its January stock offering price and convertible note conversion price, as the company burns cash amid eVTOL development.
Coca-Cola's Tax Appeal Hearing Drives Stock Surge, Spotlight on $14 Billion IRS Dispute
Coca-Cola shares surged 2.75% Friday after a federal appeals court seemed open to its arguments in a $14 billion IRS tax dispute, with analysts noting the case could lead to billions in refunds or liabilities.
Take-Two Holds Steady as GTA 6 Preorders Begin, Analysts Eye Recurring Revenue
Take-Two shares closed nearly unchanged at $238.53 as GTA VI preorders began. Analysts raised price targets, focusing on GTA Online's recurring revenue potential.
Iovance Biotherapeutics Stock Surges on $89.7 Million ATM Offering
Iovance shares rose 9.4% after launching an $89.65 million ATM stock sale, as investors balance dilution risks against the potential for accelerated Amtagvi revenue growth.
Pfizer Shares Dip as Key Lung Cancer Drug Fails Trial, Pressuring Growth Plans
Pfizer shares slipped 0.8% after a key lung cancer drug from its Seagen acquisition missed survival goals in a late-stage trial, intensifying pressure on growth plans.
AbbVie Acquires Apogee Therapeutics for $10.9B in Cash, Bolstering Pipeline
AbbVie announced a $10.9 billion cash acquisition of Apogee Therapeutics, adding a promising eczema treatment to its pipeline as it seeks to offset declining Humira sales.
SCHD Sees Inflows Surge During Dip, Data Discrepancy Raises Questions
SCHD pulled in up to $5.46B during a price dip, but flow trackers show a wide gap, raising questions about the true scale of dividend fund demand.
FDA Decisions Loom for ACHV and UNCY Amid Manufacturing Hurdles
ACHV dropped 9.5% as its FDA deadline passed with a manufacturing-related rejection expected; UNCY fell 2.8% ahead of a June 29 decision. Both stocks face third-party manufacturing issues.
Volkswagen Shares Slide After Ex-Dividend, CEO Blume Warns of Tough Restructuring
Volkswagen preferred shares dropped 4.24% to €80.53 after trading ex-dividend, as CEO Oliver Blume warned of 'critical' years ahead with 50,000 job cuts and €6 billion in annual savings targeted by 2030.
CervoMed Shares Surge on Patent News, Then Retreat After $10M Stock Offering
CervoMed shares surged to $7.75 after a U.S. patent allowance for neflamapimod in pure DLB, but gave back most gains after announcing a $10 million stock offering at $4 per share. The stock last traded at $4.14, up 8.7%.
Entergy's Grid Upgrades Tested as Arthur's Remnants Bring Flood Risk
Entergy Louisiana's $13.5 million grid-hardening project in St. Bernard Parish is tested by Arthur's remnants, potentially avoiding $24M in storm costs.
Rackspace Stock Surges on AMD AI Deal and Workforce Restructuring
Rackspace Technology shares surged 33.8% to $8.31 after finalizing an AMD AI compute deal for 30 MW of capacity and cutting 15% of its global workforce to refocus on enterprise AI.
Our Bond Soars on Debt Restructuring and City AI Security Deal
Our Bond shares surged 85% after a $3.3M debt-for-equity swap and a citywide AI security platform deployment for 270,000 residents.
Super Micro Shares Stabilize After $3.68B Convertible Offering
Super Micro Computer shares steadied at $30.85 after a $3.68 billion convertible preferred offering. Investors now await fiscal Q4 results to assess AI order conversion and margin strength.
Regentis Biomaterials Shares Retreat After Record Surge on Withdrawal of Share Offering
Regentis Biomaterials shares dropped 27.66% premarket after a 506% surge driven by the withdrawal of a planned share offering, with investors focusing on upcoming surgeon training and funding concerns.
Regentis Shares Surge After Withdrawing U.S. Share Offering
RGNT surged up to 850% after Regentis withdrew its U.S. share offering, easing dilution fears but leaving funding concerns amid a $13.6 million loss and going concern warning.
Social Security Trust Fund Depletion Moves Up to Late 2032, Pressuring Congress
Social Security's retirement trust fund depletion date has moved up to late 2032, a quarter earlier than last year, threatening 22% benefit cuts without Congressional action.
West Marine Shutters 59 Stores Amid Chapter 11 Restructuring, Executive Bonuses Draw Scrutiny
West Marine closes 59 stores in 23 states as part of Chapter 11 restructuring, with $1.075 million in retention bonuses paid to executives shortly before filing.
Momentus Shares Dive 20% on $25M Direct Offering, Dilution Fears
Momentus shares plunged 20% to $13 after pricing a $25M direct offering, raising cash but diluting existing holders. The deal closes June 15.
Redwire Stock Surges on $500M ATM Offering, Dilution Risk Weighed
Redwire shares surged 14.93% to $17.09 after filing to sell up to $500 million in new stock, about 15% of its market cap, putting dilution risk in focus.
Redwire Gains on $500M ATM Offering, Dilution Concerns Linger
Redwire shares jumped 8.3% Thursday after the company launched a $500 million ATM stock sale, raising $350 million already. Investors eye 2026 revenue target.
Freshworks Holds Steady as AI Restructuring Test Looms in Q2
Freshworks shares held flat near $9.39 on heavy volume, as investors weigh AI restructuring costs and Freshservice focus ahead of Q2 results.